Dr Roger Aston
Director
Infectious Diseases
Epichem
Australia
Biography
Roger currently serves as Chief Executive Officer of PharmAust's wholly owned subsidiary, Pitney Pharmaceuticals. Roger served as Chief Executive Officer of Mayne Pharma Group until 15 February 2012. During his career, he has been closely involved in start-up companies and major pharmaceutical companies. Aspects of his experience include FDA and EU product registration, clinical trials, global licensing agreements, fundraising through private placements, and a network of contacts within the pharmaceutical, banking and stock broking sectors. Roger is both a scientist and seasoned biotechnology entrepreneur, with a successful track record in both fields. Roger holds a B.Sc. (Hons) and a Ph.D. from the University of Manchester from 1975 to 1981.
Research Interest
Roger currently serves as Chief Executive Officer of PharmAust's wholly owned subsidiary, Pitney Pharmaceuticals. Roger served as Chief Executive Officer of Mayne Pharma Group until 15 February 2012. During his career, he has been closely involved in start-up companies and major pharmaceutical companies. Aspects of his experience include FDA and EU product registration, clinical trials, global licensing agreements, fundraising through private placements, and a network of contacts within the pharmaceutical, banking and stock broking sectors. Roger is both a scientist and seasoned biotechnology entrepreneur, with a successful track record in both fields. Roger holds a B.Sc. (Hons) and a Ph.D. from the University of Manchester from 1975 to 1981.
